--- title: "2024 Annual Meeting" description: "" url: "https://www.kentuckyacc.org/annual-meeting/meeting-archives/2024-annual-meeting" date: "2026-06-23T20:45:23+00:00" language: "en-GB" --- # 2024 Annual Meeting ![KYACC 2023 Annual Conference](https://www.kentuckyacc.org/_resources/images/meetings/2024/banner.jpg) ## Thank you to our annual meeting sponsors ![](https://www.kentuckyacc.org/media/yootheme/cache/8f/uk-kings-8fff5cb0.png)### App Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/86/canon-86e9e56f.png)### Imaging Equipment ![](https://www.kentuckyacc.org/media/yootheme/cache/bd/siemens-bd96be10.png)### Imaging Equipment ![](https://www.kentuckyacc.org/media/yootheme/cache/d6/pfizer-d610cca1.png)### Diamond Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/2e/astra-zeneca-2ebb14d1.png)### Platinum Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/de/abbott-dece449a.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/42/alnylam-429efb51.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/45/amgen-45d358c4.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/19/arh-1979fab0.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/06/baptist-health-061fea01.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/c2/bridgebio-c21f7c1e.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/ec/bms-ec63273f.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/db/cvrx-dbc758df.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/ac/edwards-acf1952b.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/5c/ge-5c8d14e4.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/2b/heartflow-2b33b61d.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/32/ionis-324886af.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/52/johnson-525baf89.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/14/merck-14219e6d.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/c2/uk-healthcare-c241e6fe.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/94/united-therapeutics-945eb304.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/5d/zywie-5d06aab1.png)### Gold Sponsor ![](https://www.kentuckyacc.org/media/yootheme/cache/00/acc-00ee9b34.png)### Non-Profit The Kentucky Academy of Cardiology will be holding its 20th Annual Meeting & Scientific Session, **September 21, 2024** at the Marriott Louisville East in Louisville, Kentucky. This is the premier educational and networking event for cardiologists and cardiovascular team members in the Commonwealth of Kentucky. This program is specifically designed for physicians, cardiac care associates, cardiovascular pharmacists, echo sonographers, nurses, and other practitioners with an emphasis on current practice trends within cardiovascular medicine. [Continuing Education](#ce) information located after the agenda. [ VIEW THE AGENDA ](#agenda) [ VIEW THE PHOTO GALLERY ](https://flic.kr/s/aHBqjBJy5k) | SATURDAY, SEPTEMBER 21, 2024 | |---| | **07:00 AM** | Registration Opens | | **07:30 AM - 09:00 AM** | Echo Machine Showcase, Posters, Exhibitors, and Breakfast | | **09:00 AM - 09:20 AM** | Governor’s Address **Speaker:** Dinesh K. Kalra, MD [ Watch the Recording](https://player.vimeo.com/video/1018438033 "2024 KY-ACC Annual Meeting") | | **09:20 AM - 10:15 AM** | [ Welcome: Current Concepts in Cardio-Oncology](#sat0920am) Navigating The Cardiovascular Crossroads Through Oncologic Therapy. Provide an Overview of Cardiotoxicity in Cancer Therapies. - Discuss interactions between cancer, cancer therapy and the heart - Discuss the role of Cardio-Oncology; Biomarkers; Risk assessment, including the guidelines - Discuss Therapy, Management and Drug Interactions via sample case scenarios **Speaker:** Tochukwu (Tochi) Okwuosa, DO, FACC, FAHA | | **10:15 AM - 10:40 AM** | Break – Posters and Exhibits | | **10:40 AM - 11:00 AM** | Honorable Maestro Award **Speaker:** Mohammed Kazimuddin, MD [ Watch the Recording](https://player.vimeo.com/video/1016501847 "2024 KY-ACC Annual Meeting") | | **11:00 AM - 11:30 AM** | Oral Abstract Presentations **Moderators:** Andrew R. Kolodziej, MD, FACC; Steve Leung, MD [ Watch - Enhancing an Inpatient Early Literacy Program Through Partnership, Access and Representation](https://player.vimeo.com/video/1016494078 "2024 KY-ACC Annual Meeting") [ Watch - Randomized Trials of Renal Denervation for Uncontrolled Hypertension](https://player.vimeo.com/video/1016502332 "2024 KY-ACC Annual Meeting") [ Watch - Trends in Lipoprotein(a) Testing within a Large Academic Health System](https://player.vimeo.com/video/1016503352 "2024 KY-ACC Annual Meeting") | | **11:30 AM - 12:10 PM** | Advocacy Update **Speakers:** Cory Meadows, KMA Director of Advocacy; Tricia Grodecki, MD; Michael Lawrence, ACC Director of State Governmental Affairs; Dinesh K. Kalra, MD **Moderator:** Jillian Leung, PharmD [ Watch the Recording](https://player.vimeo.com/video/1016492077 "2024 KY-ACC Annual Meeting") | | **12:10 PM - 01:00 PM** | [ Assessment of Competency in Cardiovascular Medicine](#sat1210pm) Address the approach to competency-based education, during cardiology fellowship and beyond, and will provide updates on physician board certification and the application for a new cardiovascular medicine board. - Get updated on the status of the application for a new cardiovascular medicine board - Understand competency-based education and how to identify knowledge gaps - Recognize the importance of assessing competence for optimization of patient care **Speaker:** Jeffrey Kuvin, MD [ Watch the Recording](https://player.vimeo.com/video/1016494341 "2024 KY-ACC Annual Meeting") | | **01:00 PM - 01:20 PM** | Break with Exhibitors | | **01:20 PM - 02:40 PM** | **Aortic Stenosis: Calcium Scoring, Low-flow/Low-gradient, TAVR, Congenital** [ Echocardiographic Evaluation of Aortic Stenosis Pre and Post Aortic Valve Replacement](#sat0120pm1) This session will provide an overview of the echocardiographic evaluation of aortic stenosis in the pre-, intra-, and post-procedure settings. Acquiring key images, making accurate measurements, grading stenosis severity, and detecting procedural complications will be reviewed. - Review the echocardiographic evaluation of aortic stenosis - Grade the severity of aortic stenosis - Detect and evaluate complications post aortic valve intervention **Speaker:** Peter Haigh, MD; Niki McKibben, BHS, RDCS [ Watch the Recording](https://player.vimeo.com/video/1018439516 "2024 KY-ACC Annual Meeting") --- [ Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome](#sat0120pm2) Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome. - Understand fetal circulation and how alterations associated with congenital heart disease affects cardiac growth - Discuss indications and patient selection criteria for fetal aortic valvuloplasty - Describe outcomes of fetal aortic valvuloplasty with postnatal evaluation and follow up **Speaker:** Adam Skaff, MD [ Watch the Recording](https://player.vimeo.com/video/1016496869 "2024 KY-ACC Annual Meeting") --- [ The Role of Cardiac CT in Pre-Procedural Planning](#sat0120pm3) - Discuss the current role of cardiac CT in TAVR procedure, patients and devices selection - Discuss the current role of cardiac CT in TMVR procedure, patients and devices selection - Discuss the current role of cardiac CT in LAAO procedure, patients and devices selection **Speaker:** Amr Idris, MD [ Watch the Recording](https://player.vimeo.com/video/1016507997 "2024 KY-ACC Annual Meeting") **Cardio-Oncology** [ Establishing and Maintaining a Multidisciplinary Amyloid Program](#sat0120pm4) Triumph over cardiac amyloidosis: the importance of multidisciplinary approach to Cardiac Amyloid. - Highlight the Importance of cardiac Amyloid management with multidisciplinary approach - Describe the University of Kentucky Amyloid Alliance - Describe the roles of various specialists of the amyloid alliance in diagnosis and management of cardiac amyloidosis **Speaker:** Andrew R. Kolodziej, MD, FACC --- [ HFpEF and Frailty/Malnourishment for Steven Heatherly](#sat0120pm5) This session aims to provide an in-depth understanding of the complex interplay between Heart Failure with preserved Ejection Fraction (HFpEF), frailty, and malnourishment. Participants will gain insights into the pathophysiology, clinical features, diagnostic criteria, and management strategies for HFpEF in patients who are frail and malnourished. Through case studies, interactive discussions, and evidence-based approaches, healthcare providers will learn to optimize care for this vulnerable patient population. - Understand the relationship between HFpEF and frailty/malnourishment - Identify the clinical features and diagnostic criteria for HFpEF in patients with frailty and malnourishment - Evaluate the management strategies and treatment options for patients with HFpEF and concurrent frailty and malnourishment **Speaker:** Steven Heatherly, MD, Ph.D., FACC [ Watch the Recording](https://player.vimeo.com/video/1016504316 "2024 KY-ACC Annual Meeting") --- [ Triumph Over Amyloidosis: A Case of Successful Dual Organ Transplant in a Patient With ATTR and AL Amyloidosis Through Multidisciplinary Care](#sat0120pm6) During this session we will review the clinical course of a patient with both ATTR and AL amyloidosis who received a dual organ transplant. We will review pre and post transplant care in patients with amyloidosis and discuss the importance of a multi-disciplinary approach. - Understand the importance of a multidisciplinary approach in the evaluation of amyloidosis - Review pre-transplant evaluation and preparation in patients with amyloidosis - Learn about postoperative care and long-term management strategies in patients with amyloidosis **Speaker:** Vasili Katsadouros, DO [ Watch the Recording](https://player.vimeo.com/video/1018441503 "2024 KY-ACC Annual Meeting") **New Pharmacotherapies, Drug-Induced Harm** [ Injecting Safe Cardiovascular Risk Reductions with Incretin Mimetics](#sat0120pm7) With more adults living with chronic health conditions and the expansion of medications focused on treatment and prevention of these conditions, the cardiology community is more focused on cardiometabolic disease and chronic health management. The use of glucagon-like peptide-1 receptor and gastric inhibitory polypeptide receptor agonists are growing in popularity, not only for diabetes management, but also weight management and cardiovascular risk reduction. While more cardiology clinicians are prescribing these agents recently, diabetes clinicians have been utilizing these agents for over a decade. It is important to appreciate the clinical experience, efficacy data, and safety profiles for these agents for our patients. - Describe the indications and efficacy data for use of GLP1R and GIP agonists - Evaluate the safety profiles for incretin mimetics to support safe and effective prescribing - Appreciate clinical practice pearls to improve patient response and tolerance to incretin mimetics **Speaker:** Tina Claypool, PharmD, CDCES, BCACP, FKSHP [ Watch the Recording](https://player.vimeo.com/video/1018438915 "2024 KY-ACC Annual Meeting") --- [ The Heart’s Hidden Imposters: Cracking the Code of HFpEF Mimics](#sat0120pm8) Identification and treatment of HFpEF mimics and safety considerations with treatment of certain HFpEF mimics. - Discuss HFpEF definition, diagnosis, and treatment - Identify and describe the definition, diagnosis, and treatment of certain cardiac HFpEF mimics - Describe the adverse events and safety considerations with treatment of HFpEF mimics **Speaker:** Holly Tyson, PharmD [ Watch the Recording](https://player.vimeo.com/video/1016502819 "2024 KY-ACC Annual Meeting") --- [ You, Me, and Her Too: Management of HER2-Targeted Cardiotoxicities](#sat0120pm9) Human Epidermal Growth Factor Receptor-2 (HER2) targeted therapies are common treatments used to manage and treat several oncologic malignancies. Since the approval of trastuzumab in 1998, patients with HER2-positive breast cancer have lived longer; however, the risk for adverse cardiac events has increased in patients treated with trastuzumab. - Explain the pathophysiologic mechanism of HER2-targeted cardiotoxicity - Describe risk stratification tools for HER2-targeted cardiotoxicity and monitoring protocols for such cardiotoxicity - Discuss management strategies to prevent HER2-targeted cardiotoxicity **Speaker:** Aaron Adkisson, PharmD, BCCP [ Watch the Recording](https://player.vimeo.com/video/1016506117 "2024 KY-ACC Annual Meeting") | | **02:40 PM - 03:00 PM** | Break with Exhibits, Posters, Echo Showcase | | **03:00 PM - 04:20 PM** | **Arrhythmias in Heart Failure** [ Arrhythmias in the Failing Fontan Patient](#sat0300pm1) - Review which patients undergo the Fontan operation and its surgical variations - Review long-term outcomes in patients s/p Fontan, including arrhythmias and heart failure - Review noninvasive and invasive management strategies for Fontan patients with arrhythmias and HF **Speaker:** Christopher Johnsrude, MD, MS [ Watch the Recording](https://player.vimeo.com/video/1016493532 "2024 KY-ACC Annual Meeting") --- [ Atrial Fibrillation and Heart Failure](#sat0300pm2) Atrial fibrillation (AF) and heart failure (HF) frequently coexist. Both are associated with significant morbidity and mortality. Appropriate AF management in HF can significantly improve outcomes. - To recognize impact of AF on HF management - To acknowledge possible benefits of maintaining normal sinus rhythm in patients with AF - To acknowledge possible benefits of maintaining normal sinus rhythm in patients with HF **Speaker:** Piotr Futyma [ Watch the Recording](https://player.vimeo.com/video/1018438456 "2024 KY-ACC Annual Meeting") --- [ Current State of Ventricular Arrhythmia Management](#sat0300pm3) Ventricular tachycardia diagnosis and management for the non EP. - Understand role of new medications to treat EP - Be aware of role of stellate ganglion block in management of VT storm - Be aware of new technologies in pipeline that may change VT ablation **Speaker:** Kevin Parrott, MD [ Watch the Recording](https://player.vimeo.com/video/1016503772 "2024 KY-ACC Annual Meeting") --- [ Device Therapy in Chronic Heart Failure](#sat0300pm4) - Review the patient selection criteria, technical considerations, and clinical data for ICD and CRT - Examine the clinical benefits of left bundle pacing in comparison to CRT therapy - Explore the potential roles of other devices, including CCM and autonomic modulation **Speaker:** Karam Ayoub, MD [ Watch the Recording](https://player.vimeo.com/video/1016495514 "2024 KY-ACC Annual Meeting") **Cardiac PET/Stress CMR** [ Chest Pain Guidelines – Role of CT and FFRCT](#sat0300pm5) This session will delve into the latest chest pain guidelines, emphasizing the pivotal role of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT). Attendees will gain insights into how these advanced imaging modalities enhance diagnostic accuracy, guide treatment decisions, and improve patient outcomes in the management of chest pain. - Review the latest guidelines for the evaluation and management of chest pain, with a focus on how these guidelines incorporate the use of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT) - Analyze the role of coronary CTA in the diagnosis and risk stratification of patients presenting with chest pain, including its accuracy, diagnostic capabilities, and integration into clinical practice **Speaker:** Mrin Shetty, MD [ Watch the Recording](https://player.vimeo.com/video/1016495061 "2024 KY-ACC Annual Meeting") --- [ CMR and Cardiomyopathy](#sat0300pm6) Advanced Cardiac Imaging in General Clinical Practice. - Understand the Role of Advanced Cardiac Imaging (Coronary CTA and Cardiac MRI) in the Assessment of Coronary Artery Disease and Cardiomyopathy - Identify Appropriate Use and Guideline Indications for the Utilization and Implementation of Coronary CTA and Cardiac MRI in Clinical Practice - Integrate Coronary CTA and Cardiac MRI into Clinical Decision-Making for Risk Stratification and Prognostication **Speaker:** Nicholas Biondi, DO [ Watch the Recording](https://player.vimeo.com/video/1016493138 "2024 KY-ACC Annual Meeting") --- [ PET for the Evaluation of Ischemic Heart Disease](#sat0300pm7) Various non-invasive imaging modalities are available for evaluating patients with ischemic heart disease. This session focuses on the use of cardiac PET in ischemic heart disease. - Discuss differences between SPECT and PET for evaluation of IHD - Understand the use of PET in evaluating patients with suspected IHD - Demonstrate the utility of cardiac PET through case illustrations **Speaker:** Talal Alnabelsi, MD [ Watch the Recording](https://player.vimeo.com/video/1018440243 "2024 KY-ACC Annual Meeting") **Pulmonary Hypertension: Guidelines, Medications** [ Navigating Sotatercept: A Roadmap for Success](#sat0300pm8) Explore critical aspects of initiating Sotatercept therapy with an emphasis on the referral process, the initial treatment phase and the nursing role in preventing treatment delays and minimizing patient harm. - Provide an overview of Sotatercept, highlighting its unique mechanism of action and potential impact on patient outcomes - Discuss the importance of patient education to streamline the referral process and enhance patient adherence - Outline the critical role of clear team communication with regards to preventing treatment delays and minimizing patient harm **Speaker:** Elaine Major, BSN, RN --- [ Pulmonary Hypertension in Fontain Heart Disease: Not Just a Pulmonary Vascular Problem](#sat0300pm9) Pediatric pulmonary hypertension definition, diagnostic algorithm, and treatment – updates from the 2024 World Symposium. - Define pulmonary hypertension in a pediatric patient - Review the diagnostic algorithm and risk stratification for children with PH - Describe the current treatment practices for children with PH **Speaker:** Clayton Allen Smith Jr., MD [ Watch the Recording](https://player.vimeo.com/video/1018440766 "2024 KY-ACC Annual Meeting") | | **04:20 PM - 04:30 PM** | Awards and Prizes | | **04:30 PM - 05:00 PM** | FIT Jeopardy **Chair:** Steve Leung, MD | ## Schema ```json { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.kentuckyacc.org" }, { "@type": "ListItem", "position": 2, "name": "2024 Annual Meeting", "item": "https://www.kentuckyacc.org/annual-meeting/meeting-archives/2024-annual-meeting" } ] } ``` ```json { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.kentuckyacc.org/annual-meeting/meeting-archives/2024-annual-meeting#organization2", "name": "Kentucky Chapter of the American College of Cardiology", "alternateName": "Agentis", "legalName": "Agentis Management", "description": "https://www.kentuckyacc.org//images/gsd.png", "email": "info@kentuckyacc.org", "url": "https://www.kentuckyacc.org", "telephone": "(859) 899-9120", "foundingDate": "1992-01-01", "logo": "https://www.kentuckyacc.org/", "image": "https://www.kentuckyacc.org/", "address": { "@type": "PostalAddress", "streetAddress": "1024 Capital Center Drive, Suite 205, Frankfort, Kentucky", "postalCode": "40601" } } ``` ```json { "@context": "https://schema.org", "@type": "Article", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.kentuckyacc.org/annual-meeting/meeting-archives/2024-annual-meeting" }, "headline": "2024 Annual Meeting", "description": "2024 Annual Meeting Thank you to our annual meeting sponsors App Sponsor Imaging Equipment Imaging Equipment Diamond Sponsor Platinum Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Gold Sponsor Non-Profit The Kentucky Academy of Cardiology will be holding its 20th Annual Meeting & Scientific Session, September 21, 2024 at the Marriott Louisville East in Louisville, Kentucky. This is the premier educational and networking event for cardiologists and cardiovascular team members in the Commonwealth of Kentucky. This program is specifically designed for physicians, cardiac care associates, cardiovascular pharmacists, echo sonographers, nurses, and other practitioners with an emphasis on current practice trends within cardiovascular medicine. Continuing Education information located after the agenda. VIEW THE AGENDA VIEW THE PHOTO GALLERY SATURDAY, SEPTEMBER 21, 2024 07:00 AM Registration Opens 07:30 AM - 09:00 AM Echo Machine Showcase, Posters, Exhibitors, and Breakfast 09:00 AM - 09:20 AM Governor’s Address Speaker: Dinesh K. Kalra, MD {modal url="https://vimeo.com/1018438033" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 09:20 AM - 10:15 AM Welcome: Current Concepts in Cardio-Oncology Navigating The Cardiovascular Crossroads Through Oncologic Therapy. Provide an Overview of Cardiotoxicity in Cancer Therapies. Discuss interactions between cancer, cancer therapy and the heart Discuss the role of Cardio-Oncology; Biomarkers; Risk assessment, including the guidelines Discuss Therapy, Management and Drug Interactions via sample case scenarios Speaker: Tochukwu (Tochi) Okwuosa, DO, FACC, FAHA 10:15 AM - 10:40 AM Break – Posters and Exhibits 10:40 AM - 11:00 AM Honorable Maestro Award Speaker: Mohammed Kazimuddin, MD {modal url="https://vimeo.com/1016501847" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 11:00 AM - 11:30 AM Oral Abstract Presentations Moderators: Andrew R. Kolodziej, MD, FACC; Steve Leung, MD {modal url="https://vimeo.com/1016494078" title="2024 KY-ACC Annual Meeting"} Watch - Enhancing an Inpatient Early Literacy Program Through Partnership, Access and Representation{/modal} {modal url="https://vimeo.com/1016502332" title="2024 KY-ACC Annual Meeting"} Watch - Randomized Trials of Renal Denervation for Uncontrolled Hypertension{/modal} {modal url="https://vimeo.com/1016503352" title="2024 KY-ACC Annual Meeting"} Watch - Trends in Lipoprotein(a) Testing within a Large Academic Health System{/modal} 11:30 AM - 12:10 PM Advocacy Update Speakers: Cory Meadows, KMA Director of Advocacy; Tricia Grodecki, MD; Michael Lawrence, ACC Director of State Governmental Affairs; Dinesh K. Kalra, MD Moderator: Jillian Leung, PharmD {modal url="https://vimeo.com/1016492077" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 12:10 PM - 01:00 PM Assessment of Competency in Cardiovascular Medicine Address the approach to competency-based education, during cardiology fellowship and beyond, and will provide updates on physician board certification and the application for a new cardiovascular medicine board. Get updated on the status of the application for a new cardiovascular medicine board Understand competency-based education and how to identify knowledge gaps Recognize the importance of assessing competence for optimization of patient care Speaker: Jeffrey Kuvin, MD {modal url="https://vimeo.com/1016494341" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 01:00 PM - 01:20 PM Break with Exhibitors 01:20 PM - 02:40 PM Aortic Stenosis: Calcium Scoring, Low-flow/Low-gradient, TAVR, Congenital Echocardiographic Evaluation of Aortic Stenosis Pre and Post Aortic Valve Replacement This session will provide an overview of the echocardiographic evaluation of aortic stenosis in the pre-, intra-, and post-procedure settings. Acquiring key images, making accurate measurements, grading stenosis severity, and detecting procedural complications will be reviewed. Review the echocardiographic evaluation of aortic stenosis Grade the severity of aortic stenosis Detect and evaluate complications post aortic valve intervention Speaker: Peter Haigh, MD; Niki McKibben, BHS, RDCS {modal url="https://vimeo.com/1018439516" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome Fetal Aortic Valvuloplasty: Promoting Left Ventricular Growth in Evolving Hypoplastic Left Heart Syndrome. Understand fetal circulation and how alterations associated with congenital heart disease affects cardiac growth Discuss indications and patient selection criteria for fetal aortic valvuloplasty Describe outcomes of fetal aortic valvuloplasty with postnatal evaluation and follow up Speaker: Adam Skaff, MD {modal url="https://vimeo.com/1016496869" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} The Role of Cardiac CT in Pre-Procedural Planning Discuss the current role of cardiac CT in TAVR procedure, patients and devices selection Discuss the current role of cardiac CT in TMVR procedure, patients and devices selection Discuss the current role of cardiac CT in LAAO procedure, patients and devices selection Speaker: Amr Idris, MD {modal url="https://vimeo.com/1016507997" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Cardio-Oncology Establishing and Maintaining a Multidisciplinary Amyloid Program Triumph over cardiac amyloidosis: the importance of multidisciplinary approach to Cardiac Amyloid. Highlight the Importance of cardiac Amyloid management with multidisciplinary approach Describe the University of Kentucky Amyloid Alliance Describe the roles of various specialists of the amyloid alliance in diagnosis and management of cardiac amyloidosis Speaker: Andrew R. Kolodziej, MD, FACC HFpEF and Frailty/Malnourishment for Steven Heatherly This session aims to provide an in-depth understanding of the complex interplay between Heart Failure with preserved Ejection Fraction (HFpEF), frailty, and malnourishment. Participants will gain insights into the pathophysiology, clinical features, diagnostic criteria, and management strategies for HFpEF in patients who are frail and malnourished. Through case studies, interactive discussions, and evidence-based approaches, healthcare providers will learn to optimize care for this vulnerable patient population. Understand the relationship between HFpEF and frailty/malnourishment Identify the clinical features and diagnostic criteria for HFpEF in patients with frailty and malnourishment Evaluate the management strategies and treatment options for patients with HFpEF and concurrent frailty and malnourishment Speaker: Steven Heatherly, MD, Ph.D., FACC {modal url="https://vimeo.com/1016504316" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Triumph Over Amyloidosis: A Case of Successful Dual Organ Transplant in a Patient With ATTR and AL Amyloidosis Through Multidisciplinary Care During this session we will review the clinical course of a patient with both ATTR and AL amyloidosis who received a dual organ transplant. We will review pre and post transplant care in patients with amyloidosis and discuss the importance of a multi-disciplinary approach. Understand the importance of a multidisciplinary approach in the evaluation of amyloidosis Review pre-transplant evaluation and preparation in patients with amyloidosis Learn about postoperative care and long-term management strategies in patients with amyloidosis Speaker: Vasili Katsadouros, DO {modal url="https://vimeo.com/1018441503" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} New Pharmacotherapies, Drug-Induced Harm Injecting Safe Cardiovascular Risk Reductions with Incretin Mimetics With more adults living with chronic health conditions and the expansion of medications focused on treatment and prevention of these conditions, the cardiology community is more focused on cardiometabolic disease and chronic health management. The use of glucagon-like peptide-1 receptor and gastric inhibitory polypeptide receptor agonists are growing in popularity, not only for diabetes management, but also weight management and cardiovascular risk reduction. While more cardiology clinicians are prescribing these agents recently, diabetes clinicians have been utilizing these agents for over a decade. It is important to appreciate the clinical experience, efficacy data, and safety profiles for these agents for our patients. Describe the indications and efficacy data for use of GLP1R and GIP agonists Evaluate the safety profiles for incretin mimetics to support safe and effective prescribing Appreciate clinical practice pearls to improve patient response and tolerance to incretin mimetics Speaker: Tina Claypool, PharmD, CDCES, BCACP, FKSHP {modal url="https://vimeo.com/1018438915" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} The Heart’s Hidden Imposters: Cracking the Code of HFpEF Mimics Identification and treatment of HFpEF mimics and safety considerations with treatment of certain HFpEF mimics. Discuss HFpEF definition, diagnosis, and treatment Identify and describe the definition, diagnosis, and treatment of certain cardiac HFpEF mimics Describe the adverse events and safety considerations with treatment of HFpEF mimics Speaker: Holly Tyson, PharmD {modal url="https://vimeo.com/1016502819" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} You, Me, and Her Too: Management of HER2-Targeted Cardiotoxicities Human Epidermal Growth Factor Receptor-2 (HER2) targeted therapies are common treatments used to manage and treat several oncologic malignancies. Since the approval of trastuzumab in 1998, patients with HER2-positive breast cancer have lived longer; however, the risk for adverse cardiac events has increased in patients treated with trastuzumab. Explain the pathophysiologic mechanism of HER2-targeted cardiotoxicity Describe risk stratification tools for HER2-targeted cardiotoxicity and monitoring protocols for such cardiotoxicity Discuss management strategies to prevent HER2-targeted cardiotoxicity Speaker: Aaron Adkisson, PharmD, BCCP {modal url="https://vimeo.com/1016506117" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 02:40 PM - 03:00 PM Break with Exhibits, Posters, Echo Showcase 03:00 PM - 04:20 PM Arrhythmias in Heart Failure Arrhythmias in the Failing Fontan Patient Review which patients undergo the Fontan operation and its surgical variations Review long-term outcomes in patients s/p Fontan, including arrhythmias and heart failure Review noninvasive and invasive management strategies for Fontan patients with arrhythmias and HF Speaker: Christopher Johnsrude, MD, MS {modal url="https://vimeo.com/1016493532" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Atrial Fibrillation and Heart Failure Atrial fibrillation (AF) and heart failure (HF) frequently coexist. Both are associated with significant morbidity and mortality. Appropriate AF management in HF can significantly improve outcomes. To recognize impact of AF on HF management To acknowledge possible benefits of maintaining normal sinus rhythm in patients with AF To acknowledge possible benefits of maintaining normal sinus rhythm in patients with HF Speaker: Piotr Futyma {modal url="https://vimeo.com/1018438456" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Current State of Ventricular Arrhythmia Management Ventricular tachycardia diagnosis and management for the non EP. Understand role of new medications to treat EP Be aware of role of stellate ganglion block in management of VT storm Be aware of new technologies in pipeline that may change VT ablation Speaker: Kevin Parrott, MD {modal url="https://vimeo.com/1016503772" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Device Therapy in Chronic Heart Failure Review the patient selection criteria, technical considerations, and clinical data for ICD and CRT Examine the clinical benefits of left bundle pacing in comparison to CRT therapy Explore the potential roles of other devices, including CCM and autonomic modulation Speaker: Karam Ayoub, MD {modal url="https://vimeo.com/1016495514" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Cardiac PET/Stress CMR Chest Pain Guidelines – Role of CT and FFRCT This session will delve into the latest chest pain guidelines, emphasizing the pivotal role of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT). Attendees will gain insights into how these advanced imaging modalities enhance diagnostic accuracy, guide treatment decisions, and improve patient outcomes in the management of chest pain. Review the latest guidelines for the evaluation and management of chest pain, with a focus on how these guidelines incorporate the use of coronary CT angiography (CTA) and fractional flow reserve CT (FFRCT) Analyze the role of coronary CTA in the diagnosis and risk stratification of patients presenting with chest pain, including its accuracy, diagnostic capabilities, and integration into clinical practice Speaker: Mrin Shetty, MD {modal url="https://vimeo.com/1016495061" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} CMR and Cardiomyopathy Advanced Cardiac Imaging in General Clinical Practice. Understand the Role of Advanced Cardiac Imaging (Coronary CTA and Cardiac MRI) in the Assessment of Coronary Artery Disease and Cardiomyopathy Identify Appropriate Use and Guideline Indications for the Utilization and Implementation of Coronary CTA and Cardiac MRI in Clinical Practice Integrate Coronary CTA and Cardiac MRI into Clinical Decision-Making for Risk Stratification and Prognostication Speaker: Nicholas Biondi, DO {modal url="https://vimeo.com/1016493138" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} PET for the Evaluation of Ischemic Heart Disease Various non-invasive imaging modalities are available for evaluating patients with ischemic heart disease. This session focuses on the use of cardiac PET in ischemic heart disease. Discuss differences between SPECT and PET for evaluation of IHD Understand the use of PET in evaluating patients with suspected IHD Demonstrate the utility of cardiac PET through case illustrations Speaker: Talal Alnabelsi, MD {modal url="https://vimeo.com/1018440243" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} Pulmonary Hypertension: Guidelines, Medications Navigating Sotatercept: A Roadmap for Success Explore critical aspects of initiating Sotatercept therapy with an emphasis on the referral process, the initial treatment phase and the nursing role in preventing treatment delays and minimizing patient harm. Provide an overview of Sotatercept, highlighting its unique mechanism of action and potential impact on patient outcomes Discuss the importance of patient education to streamline the referral process and enhance patient adherence Outline the critical role of clear team communication with regards to preventing treatment delays and minimizing patient harm Speaker: Elaine Major, BSN, RN Pulmonary Hypertension in Fontain Heart Disease: Not Just a Pulmonary Vascular Problem Pediatric pulmonary hypertension definition, diagnostic algorithm, and treatment – updates from the 2024 World Symposium. Define pulmonary hypertension in a pediatric patient Review the diagnostic algorithm and risk stratification for children with PH Describe the current treatment practices for children with PH Speaker: Clayton Allen Smith Jr., MD {modal url="https://vimeo.com/1018440766" title="2024 KY-ACC Annual Meeting"} Watch the Recording{/modal} 04:20 PM - 04:30 PM Awards and Prizes 04:30 PM - 05:00 PM FIT Jeopardy Chair: Steve Leung, MD", "image": { "@type": "ImageObject", "url": "https://www.kentuckyacc.org/" }, "publisher": { "@type": "Organization", "name": "Kentucky Chapter of the American College of Cardiology", "logo": { "@type": "ImageObject", "url": "https://www.kentuckyacc.org//images/gsd.png" } }, "author": { "@type": "Person", "name": "Paul Scarnegie", "url": "https://www.kentuckyacc.org/annual-meeting/meeting-archives/2024-annual-meeting" }, "datePublished": "2024-07-25T18:59:18+00:00", "dateCreated": "2024-07-25T18:59:18+00:00", "dateModified": "2026-06-18T14:34:52+00:00" } ```